{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:17:57Z","timestamp":1791839877645,"version":"4.3.4"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,25]]},"abstract":"<jats:p>The cases of two patients with erythrodermic pityriasis rubra pilaris that showed a rapid and virtually complete response to tildrakizumab are presented. Treatment of pityriasis rubra pilaris remains challenging and there is very little evidence about use of interleukin-23 blockers in this condition. These cases may contribute to extending the available therapeutic options, especially when a fast clearance of the lesions is needed.<\/jats:p>","DOI":"10.1093\/ced\/llad352","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T19:47:09Z","timestamp":1697572029000},"page":"177-180","source":"Crossref","is-referenced-by-count":6,"title":["Rapid response of erythrodermic pityriasis rubra pilaris to tildrakizumab"],"prefix":"10.1093","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-0581","authenticated-orcid":false,"given":"Jose Maria","family":"Villa-Gonzalez","sequence":"first","affiliation":[{"name":"Department of Dermatology at Cruces University Hospital , Barakaldo, Biscay , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0698-2466","authenticated-orcid":false,"given":"Maria Rosario","family":"Gonzalez-Hermosa","sequence":"additional","affiliation":[{"name":"Department of Dermatology at Cruces University Hospital , Barakaldo, Biscay , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Atxutegi-Ayesta","sequence":"additional","affiliation":[{"name":"Department of Dermatology at Cruces University Hospital , Barakaldo, Biscay , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Rat\u00f3n Nieto","sequence":"additional","affiliation":[{"name":"Department of Dermatology at Cruces University Hospital , Barakaldo, Biscay , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Gardeazabal Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Dermatology at Cruces University Hospital , Barakaldo, Biscay , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olatz","family":"Lasa Elgezua","sequence":"additional","affiliation":[{"name":"Department of Dermatology at Cruces University Hospital , Barakaldo, Biscay , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"2024012519205341400_llad352-B1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamadermatol.2016.5384","article-title":"Interleukin 23\u2013helper T cell 17 axis as a treatment target for pityriasis rubra pilaris","volume":"153","author":"Feldmeyer","year":"2017","journal-title":"JAMA Dermatol"},{"key":"2024012519205341400_llad352-B2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaad.2018.03.036","article-title":"Biologics for pityriasis rubra pilaris treatment: a review of the literature","volume":"79","author":"Napolitano","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2024012519205341400_llad352-B3","first-page":"243","article-title":"Systemic therapies of pityriasis rubra pilaris: a systematic review","volume":"17","author":"Kromer","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"2024012519205341400_llad352-B4","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/ced.14790","article-title":"Refractory type I pityriasis rubra pilaris treated with tildrakizumab","volume":"46","author":"Licata","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"2024012519205341400_llad352-B5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/ajd.13753","article-title":"Successful treatment of pityriasis rubra\u00a0pilaris with tildrakizumab","volume":"63","author":"Zagarella","year":"2022","journal-title":"Australas J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad352\/53484670\/llad352.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/2\/177\/56420889\/llad352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/2\/177\/56420889\/llad352.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T19:21:10Z","timestamp":1706210470000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/2\/177\/7320051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":5,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,10,17]]},"published-print":{"date-parts":[[2024,1,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad352","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,10,17]]}}}